banner
33
曹彬#*. 《流行性感冒诊疗方案(2020年版)》之我见. 中华结核和呼吸杂志. 2021,44(06): 523-524.
34
王业明#, 徐逸天, 曹彬*. 新型冠状病毒感染传播、发病机制、诊断和治疗的进展. 中华结核和呼吸杂志. 2021,44(07): 684-688.
35
徐逸天#, 曹彬*. 病毒性感染中毒症——一个亟待重视的概念. 中华结核和呼吸杂志. 2021,44(07): 674-679.
36
Zhou C#, Jin L, Wang Q, Wang X, Chen F, Gao Y, Zhao C, Chen H, Cao B, Wang H*. Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales: Risk Factors for Mortality, Antimicrobial Therapy and Treatment Outcomes from a Prospective Multicenter Study. Infect Drug Resist. 2021 Feb 24;14:731-742. doi: 10.2147/IDR.S294282. eCollection 2021.
37
Huang L#, Wang J,Gu X, Sheng W, Wang Y, Cao B*. Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicenter randomised controlled trial. BMJ Open. 2021 Aug 5;11(8):e049515. doi: 10.1136/bmjopen-2021-049515.
38
Huang L#, Gu X, Wang Y, Huang C, Cao B*. Long-term effects of COVID-19 on kidney function Reply. Lancet. 2021 May 15;397(10287):1807-1808. doi: 10.1016/S0140-6736(21)00875-8.
39
Zhao H#, Wei L, Li H, Zhang M, Cao B, Bian J*, Zhan S*. Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study. Lancet Infect Dis. 2021 Jun;21(6):847-857. doi: 10.1016/S1473-3099(20)30596-X. Epub 2021 Jan 27.
40
Zou X#, Cao B*. COVID-19 vaccines for children younger than 12 years: are we ready? Lancet Infect Dis. 2021 Dec;21(12):1614-1615. doi: 10.1016/S1473-3099(21)00384-4. Epub 2021 Jun 28.
41
Liu B#, Bao L#, Wang L#, Li F, Wen M, Li H, Deng W, Zhang X, Cao B*. Anti-IFN-gamma therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice. J Microbiol Immunol Infect. 2021 Jun;54(3):396-403. doi: 10.1016/j.jmii.2019.07.009. Epub 2019 Nov 12.
42
Huang L#, Yao Q#, Gu X#, Wang Q#, Ren L#, Wang Y#, Hu P#, Guo L#, Liu M, Xu J, Zhang X, Qu Y, Fan Y, Li X, Li C, Yu T, Xia J, Wei M, Chen L, Li Y, Xiao F, Liu D, Wang J*, Wang X*, Cao B*. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021 Aug 28;398(10302):747-758. doi: 10.1016/S0140-6736(21)01755-4.
43
Sun L#, Li H, Wang Q, Liu Y*, Cao B*. Increased gene expression and copy number of mutated bla(KPC) lead to high-level ceftazidime/avibactam resistance in Klebsiella pneumoniae. BMC Microbiol. 2021 Aug 19;21(1):230. doi: 10.1186/s12866-021-02293-0.
44
Li H#, Yu J, Cao B*. SARS-CoV-2 vaccination for immune-comprised patients: More is required. Lancet Reg Health Eur. 2021 Oct;9:100191. doi: 10.1016/j.lanepe.2021.100191. Epub 2021 Aug 18.
45
Wu Xu#, Bao L#, Hu Z, Yao D, Li F, Li H, Xu X, An Y, Wang X, Cao B*, Zhang X*. Ficolin A exacerbates severe H1N1 influenza virus infection-induced acute lung immunopathological injury via excessive complement activation. Cell Mol Immunol. 2021 Sep;18(9):2278-2280. doi: 10.1038/s41423-021-00737-1. Epub 2021 Jul 23.
46
Duan S#, Gu X, Fan G, Zhou F, Zhu G, Cao B*. C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections. BMC Pulm Med. 2021 Sep 28;21(1):308. doi: 10.1186/s12890-021-01672-7.
47
Wang C#, Zhao J#, Liu Z#, Sun A#, Sun L, Li B, Lu B, Liu Y, Cao B*. In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase. Front Microbiol. 2021 Sep 23;12:727946. doi: 10.3389/fmicb.2021.727946. eCollection 2021.
48
Ren L#, Wang Y#,, Zhong J#,, Li X, Xiao Y, Li J, Yang J, Fan G, Guo L, Shen Z, Kang L, Shi L, Li Q, Li J, Di L, Li H, Wang C, Wang Y, Wang X, Zou X, Rao J, Zhang L, Wang J, Huang Y, Cao B*, Wang J*, Li M*. Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1379-1390. doi: 10.1164/rccm.202103-0814OC.